a b s t r a c t Pemphigus are blistering autoimmune diseases related with genetic and environmental factors. Here we describe HLA genotyping in pemphigus patients. First, we review the HLA class I/II data on pemphigus reported in Brazilian samples and then present the HLA class I (-A, -B, -C) and class II (-DRB1, -DQA1, -DQB1) alleles related to susceptibility/resistance to pemphigus by comparing 86 patients with pemphigus foliaceus, 83 patients with pemphigus vulgaris, and 1592 controls from the northeastern region of the state of São Paulo, Southeastern Brazil. The data presented here are related to the manuscript "Differential HLA class I and class II associations in Pemphigus Foliaceus and Pemphigus Vulgaris patients from a prevalent Southeastern Brazilian region" Brochado et al. (2016) [1].
Specifications

Value of the data
The literature review regarding HLA class I/II data on pemphigus is shown in tables comparing different studied Brazilian populations.
The northeastern region of the state of São Paulo, Southeastern Brazil, is prevalent for both clinical forms of pemphigus-pemphigus foliaceus and pemphigus vulgaris, enabling a comparative study.
HLA class I/II frequencies are detailed comparing pemphigus foliaceus and pemphigus vulgaris patients from the same endemic region.
Data
Tables 1 and 2 describe the HLA class I and II data related to susceptibility/resistance to pemphigus foliaceus and pemphigus vulgaris in reviewed Brazilian reports. Tables 3-8 show the HLA class I (-A, -B, -C) and class II (-DRB1, -DQA1, -DQB1) profile performed in pemphigus foliaceus and pemphigus vulgaris patients from Southeastern Brazil.
Experimental design, materials, and methods
A summary of Brazilian data regarding associations between HLA and pemphigus was obtained in PubMed. A hundred and sixty-nine patients followed up at the University Hospital of the Ribeirão Preto Medical School of the University of São Paulo, Brazil, were evaluated. Eighty-six and 83 patients exhibited PF and PV, respectively. The control group consisted of 1592 healthy individuals living in the northeastern region of the state of São Paulo, Southeastern Brazil. HLA class I and II typing was performed at low/high resolution by using commercial kits, according to the manufacturer's protocol (One Lambda Inc., Canoga Park, CA). The allelic frequencies of the HLA class I and II genes were estimated by direct counting. Comparison of allele frequency among the groups was performed by using Fisher's exact test or the Chi-square test. Significant P-values were corrected by the number of alleles tested for each locus. The relative risk (RR) 95% was estimated. Statistical analysis was performed with SAS 9.3 (SAS Institute Inc, EUA) and Epi InfoTM 7.0 (CDC, USA) software. Values P r0.05 were considered significant. All the participants provided an informed written consent to participate in this study. The local Ethics Committee (#12248/2010) approved this study. 
